Laertis Ikonomou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Laertis Ikonomou has a total of 302 co-authors. Here are the top co-authors by number of shared publications:
Daniel J. Weiss
10 shared publications- Darrell N. Kotton
Boston University
8 shared publications Aaron D. Levine
School of Public Policy, Georgia Institute of Technology, Atlanta, Georgia, USA
5 shared publications- Darcy Elizabeth Wagner
LUCC Lund University Cancer Center, Lund University, Lund, Sweden
5 shared publications - Leigh Turner
Department of Health, Society, and Behavior, University of California Irvine Irvine, CA 92697
5 shared publications - Pankaj Mehta
Department of Physics, Boston University
5 shared publications
Latest Publications
- 29 July 2026
- Published by Elsevier in Cytotherapy
- Vol. 29 (1)
Cell therapies: are we doing enough to protect patients and address the barriers to patient access?
- 29 July 2026
- Published by Elsevier in Cytotherapy
- Vol. 29 (1)
Cell therapies: are we doing enough to protect patients and address the barriers to patient access?
- Open Access
- 3 May 2026
- Published by Elsevier in Cytotherapy
- Vol. 28 (10)
Litigating the Hype: The Lung Health Institute Class Action and Its Implications
- 3 May 2026
- Published by Elsevier in Cytotherapy
- Vol. 28 (10)
Open AccessLitigating the Hype: The Lung Health Institute Class Action and Its Implications
- Open Access
Finding signatures of low-dimensional geometric landscapes in high-dimensional cell fate transitions
Multicellular organisms develop a wide variety of highly-specialized cell types. The consistency and robustness of developmental cell fate trajectories suggests that complex gene regulatory networks effectively act as low-dimensional cell fate landscapes. A complementary set of works draws on the theory of dynamical systems to argue that cell fate transitions can be categorized into universal decision-making classes. However, the theory connecting geometric landscapes and decision-making classes to high-dimensional gene expression space is still in its infancy. Here, we introduce a phenomenological model that allows us to identify gene expression signatures of decision-making classes from single-cell RNA-sequencing time-series data. Our model combines low-dimensional gradient-like dynamical systems and high-dimensional Hopfield networks to capture the interplay between cell fate, gene expression, and signaling pathways. We apply our model to the maturation of alveolar cells in mouse lungs to show that the transient appearance of a mixed alveolar type 1/type 2 state suggests the triple cusp decision-making class. We also analyze lineage-tracing data on hematopoetic differentiation and show that bipotent neutrophil-monocyte progenitors likely undergo a heteroclinic flip bifurcation. Our results suggest it is possible to identify universal decision-making classes for cell fate transitions directly from data.
Open AccessFinding signatures of low-dimensional geometric landscapes in high-dimensional cell fate transitions
Multicellular organisms develop a wide variety of highly-specialized cell types. The consistency and robustness of developmental cell fate trajectories suggests that complex gene regulatory networks effectively act as low-dimensional cell fate landscapes. A complementary set of works draws on the theory of dynamical systems to argue that cell fate transitions can be categorized into universal decision-making classes. However, the theory connecting geometric landscapes and decision-making classes to high-dimensional gene expression space is still in its infancy. Here, we introduce a phenomenological model that allows us to identify gene expression signatures of decision-making classes from single-cell RNA-sequencing time-series data. Our model combines low-dimensional gradient-like dynamical systems and high-dimensional Hopfield networks to capture the interplay between cell fate, gene expression, and signaling pathways. We apply our model to the maturation of alveolar cells in mouse lungs to show that the transient appearance of a mixed alveolar type 1/type 2 state suggests the triple cusp decision-making class. We also analyze lineage-tracing data on hematopoetic differentiation and show that bipotent neutrophil-monocyte progenitors likely undergo a heteroclinic flip bifurcation. Our results suggest it is possible to identify universal decision-making classes for cell fate transitions directly from data.
- Open Access
- 7 February 2025
- Published by Elsevier in Cytotherapy
- Vol. 27 (6) , 671-677
International Society for Cell & Gene Therapy Expanded Access Working Group position paper: key considerations to support equitable and ethical expanded access to investigational cell- and gene-based interventions
- 7 February 2025
- Published by Elsevier in Cytotherapy
- Vol. 27 (6) , 671-677
Open AccessInternational Society for Cell & Gene Therapy Expanded Access Working Group position paper: key considerations to support equitable and ethical expanded access to investigational cell- and gene-based interventions
- 3 October 2024
- Published by Elsevier in Cell Stem Cell
- Vol. 31 (10) , 1393-1397
Effective regulatory responses to predatory stem cell markets in Australia and Canada
- 3 October 2024
- Published by Elsevier in Cell Stem Cell
- Vol. 31 (10) , 1393-1397
Effective regulatory responses to predatory stem cell markets in Australia and Canada
- Open Access
- 1 September 2024
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 327 (3) , L327-L340
Stem cells, cell therapies, and bioengineering in lung biology and diseases 2023
Repair and regeneration of a diseased lung using stem cells or bioengineered tissues is an exciting therapeutic approach for a variety of lung diseases and critical illnesses. Over the past decade, increasing evidence from preclinical models suggests that mesenchymal stromal cells, which are not normally resident in the lung, can be used to modulate immune responses after injury, but there have been challenges in translating these promising findings to the clinic. In parallel, there has been a surge in bioengineering studies investigating the use of artificial and acellular lung matrices as scaffolds for three-dimensional lung or airway regeneration, with some recent attempts of transplantation in large animal models. The combination of these studies with those involving stem cells, induced pluripotent stem cell derivatives, and/or cell therapies is a promising and rapidly developing research area. These studies have been further paralleled by significant increases in our understanding of the molecular and cellular events by which endogenous lung stem and/or progenitor cells arise during lung development and participate in normal and pathological remodeling after lung injury. For the 2023 Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Diseases Conference, scientific symposia were chosen to reflect the most cutting-edge advances in these fields. Sessions focused on the integration of “omics” technologies with function, the influence of immune cells on regeneration, and the role of the extracellular matrix in regeneration. The necessity for basic science studies to enhance fundamental understanding of lung regeneration and to design innovative translational studies was reinforced throughout the conference.
- 1 September 2024
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 327 (3) , L327-L340
Open AccessStem cells, cell therapies, and bioengineering in lung biology and diseases 2023
Repair and regeneration of a diseased lung using stem cells or bioengineered tissues is an exciting therapeutic approach for a variety of lung diseases and critical illnesses. Over the past decade, increasing evidence from preclinical models suggests that mesenchymal stromal cells, which are not normally resident in the lung, can be used to modulate immune responses after injury, but there have been challenges in translating these promising findings to the clinic. In parallel, there has been a surge in bioengineering studies investigating the use of artificial and acellular lung matrices as scaffolds for three-dimensional lung or airway regeneration, with some recent attempts of transplantation in large animal models. The combination of these studies with those involving stem cells, induced pluripotent stem cell derivatives, and/or cell therapies is a promising and rapidly developing research area. These studies have been further paralleled by significant increases in our understanding of the molecular and cellular events by which endogenous lung stem and/or progenitor cells arise during lung development and participate in normal and pathological remodeling after lung injury. For the 2023 Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Diseases Conference, scientific symposia were chosen to reflect the most cutting-edge advances in these fields. Sessions focused on the integration of “omics” technologies with function, the influence of immune cells on regeneration, and the role of the extracellular matrix in regeneration. The necessity for basic science studies to enhance fundamental understanding of lung regeneration and to design innovative translational studies was reinforced throughout the conference.
- Open Access
- 11 August 2023
- Published by Springer Nature
- Vol. 1413, C3-C4
Correction to: Multipotent Embryonic Lung Progenitors: Foundational Units of In Vitro and In Vivo Lung Organogenesis
- 11 August 2023
- Published by Springer Nature
- Vol. 1413, C3-C4
Open AccessCorrection to: Multipotent Embryonic Lung Progenitors: Foundational Units of In Vitro and In Vivo Lung Organogenesis
- Open Access
- 28 July 2023
- Published by Elsevier in Cytotherapy
- Vol. 25 (9) , 920-929
International Society for Cell & Gene Therapy Position Paper: Key considerations to support evidence-based cell and gene therapies and oppose marketing of unproven products
- 28 July 2023
- Published by Elsevier in Cytotherapy
- Vol. 25 (9) , 920-929
Open AccessInternational Society for Cell & Gene Therapy Position Paper: Key considerations to support evidence-based cell and gene therapies and oppose marketing of unproven products
- Open Access
- 13 June 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-18
Directed differentiation of mouse pluripotent stem cells into functional lung-specific mesenchyme
While the generation of many lineages from pluripotent stem cells has resulted in basic discoveries and clinical trials, the derivation of tissue-specific mesenchyme via directed differentiation has markedly lagged. The derivation of lung-specific mesenchyme is particularly important since this tissue plays crucial roles in lung development and disease. Here we generate a mouse induced pluripotent stem cell (iPSC) line carrying a lung-specific mesenchymal reporter/lineage tracer. We identify the pathways (RA and Shh) necessary to specify lung mesenchyme and find that mouse iPSC-derived lung mesenchyme (iLM) expresses key molecular and functional features of primary developing lung mesenchyme. iLM recombined with engineered lung epithelial progenitors self-organizes into 3D organoids with juxtaposed layers of epithelium and mesenchyme. Co-culture increases yield of lung epithelial progenitors and impacts epithelial and mesenchymal differentiation programs, suggesting functional crosstalk. Our iPSC-derived population thus provides an inexhaustible source of cells for studying lung development, modeling diseases, and developing therapeutics.
- 13 June 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-18
Open AccessDirected differentiation of mouse pluripotent stem cells into functional lung-specific mesenchyme
While the generation of many lineages from pluripotent stem cells has resulted in basic discoveries and clinical trials, the derivation of tissue-specific mesenchyme via directed differentiation has markedly lagged. The derivation of lung-specific mesenchyme is particularly important since this tissue plays crucial roles in lung development and disease. Here we generate a mouse induced pluripotent stem cell (iPSC) line carrying a lung-specific mesenchymal reporter/lineage tracer. We identify the pathways (RA and Shh) necessary to specify lung mesenchyme and find that mouse iPSC-derived lung mesenchyme (iLM) expresses key molecular and functional features of primary developing lung mesenchyme. iLM recombined with engineered lung epithelial progenitors self-organizes into 3D organoids with juxtaposed layers of epithelium and mesenchyme. Co-culture increases yield of lung epithelial progenitors and impacts epithelial and mesenchymal differentiation programs, suggesting functional crosstalk. Our iPSC-derived population thus provides an inexhaustible source of cells for studying lung development, modeling diseases, and developing therapeutics.
- 17 May 2023
- Published by Springer Nature
- Vol. 1413, 49-70
Multipotent Embryonic Lung Progenitors: Foundational Units of In Vitro and In Vivo Lung Organogenesis
Transient, tissue-specific, embryonic progenitors are important cell populations in vertebrate development. In the course of respiratory system development, multipotent mesenchymal and epithelial progenitors drive the diversification of fates that results to the plethora of cell types that compose the airways and alveolar space of the adult lungs. Use of mouse genetic models, including lineage tracing and loss-of-function studies, has elucidated signaling pathways that guide proliferation and differentiation of embryonic lung progenitors as well as transcription factors that underlie lung progenitor identity. Furthermore, pluripotent stem cell-derived and ex vivo expanded respiratory progenitors offer novel, tractable, high-fidelity systems that allow for mechanistic studies of cell fate decisions and developmental processes. As our understanding of embryonic progenitor biology deepens, we move closer to the goal of in vitro lung organogenesis and resulting applications in developmental biology and medicine.
- 17 May 2023
- Published by Springer Nature
- Vol. 1413, 49-70
Multipotent Embryonic Lung Progenitors: Foundational Units of In Vitro and In Vivo Lung Organogenesis
Transient, tissue-specific, embryonic progenitors are important cell populations in vertebrate development. In the course of respiratory system development, multipotent mesenchymal and epithelial progenitors drive the diversification of fates that results to the plethora of cell types that compose the airways and alveolar space of the adult lungs. Use of mouse genetic models, including lineage tracing and loss-of-function studies, has elucidated signaling pathways that guide proliferation and differentiation of embryonic lung progenitors as well as transcription factors that underlie lung progenitor identity. Furthermore, pluripotent stem cell-derived and ex vivo expanded respiratory progenitors offer novel, tractable, high-fidelity systems that allow for mechanistic studies of cell fate decisions and developmental processes. As our understanding of embryonic progenitor biology deepens, we move closer to the goal of in vitro lung organogenesis and resulting applications in developmental biology and medicine.